At Alfa Cytology, we offer a comprehensive suite of preclinical services tailored to advance cancer research and drug development. Our one-stop preclinical platform provides end-to-end solutions, from disease modeling and diagnostic development to therapeutic evaluation - all under one roof.

Our Focus Area

Alfa Cytology’s research portfolio covers a broad spectrum of malignancies, from breast and lung to gastric, bladder, and select hematologic cancers. This multi-cancer focus enables cross-disciplinary insight and tailored experimental models for diverse drug-discovery programs.

Download

Breast Cancer

Prostate Cancer

Lung Cancer

Ovarian Cancer

Bladder Cancer

Brain Cancer

Liver Cancer

Renal Cell Carcinoma

Hematologic Cancer

More

Modeling Services

Alfa Cytology evaluates drug efficacy across a spectrum of in-vitro platforms—including 2D cell panels, 3D spheroids, and organoid cultures—to capture mechanistic and dose-response insights. These results are corroborated in vivo using xenograft, orthotopic, and patient-derived mouse models, yielding a comprehensive view of therapeutic performance.

In Vitro Cancer Model

• Cell Line Models
• Organoids
• Organ-on-a-chip Models
• Scaffold-Based 3D Cellular Models

In Vivo Cancer Model

• Syngeneic Models
• Patient-Derived Xenograft(PDX)Models
• Cell Line Xenograft(CDX)Models
• Genetically Engineered Models(GEMs)

Key Advantages:

Diverse Cancer Models - We maintain a wide range of cancer cell lines, patient-derived xenografts, and genetically engineered mouse models to accurately reflect the heterogeneity of various cancer types.

Efficient Therapeutic Screening - Our high-throughput screening capabilities and in vivo testing platforms accelerate the evaluation of novel drug candidates and combination therapies.

Integrated Data Analysis - Our experienced team provides comprehensive data analysis and reporting to guide your research and development decisions.

Regulatory Compliance - We adhere to the highest standards of quality, safety, and ethical practices to ensure your preclinical studies meet regulatory requirements.

With our extensive expertise and integrated services, we are your trusted partner in accelerating cancer research and driving breakthroughs in diagnostics and therapeutics. Please contact us for more information.

Diagnostic Development Platform

Cancer Biomarker Discovery
Imaging Services
Multi-omics Services

Cancer Modeling Platform

Advanced Cellular Models
3D Tumor Modeling
PDX Model
CDX Model
Syngeneic Tumor Model

Therapeutic Development Platform

Small Molecule Drug
Cell Therapy
Gene Therapy

Antibody
Therapeutic Peptide
Cancer Vaccine